Delivery Order SPE2DB20D2104-SPE2DB25FMXNR
- Not listed
- The Defense Logistics Agency awarded a $23,545.12 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 28, 2025, and fulfillment from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a delivery order valued at $93,147.08 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on July 30, 2025. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. The award represents a single delivery order execution under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a $63,097.82 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of NURTEC ODT 75 MG tablets (quantity: 8 units). This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $81,621.43 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and specifies AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,430.53 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 21, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.5K to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract fulfilling federal medical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXNRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packaging) under a firm fixed-price contract with a ceiling value of $2,564.82. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial IDC with the Defense Logistics Agency enables it to supply a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support defense health operations globally. This specific delivery order for NURTEC ODT, a migraine treatment medication, represents a routine fulfillment under the company's extensive pharmaceutical supply agreement with the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/12/25 |